☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
cemiplimab
PharmaShots Interview: Dr. Ahmet Sezer, Karl Lewis, and Regeneron's Israel Lowy Share Insights on Libtayo (cemiplimab) for NSCLC &...
September 29, 2021
PharmaShots Interview: Dr. Sezer, Peter C. Adamson and Israel Lowy Share Insight on the US FDA's Approval of Libtayo (cemiplimab)...
March 30, 2021
Regeneron Collaborates with BioNTech to Advance the Combination of FixVac and Libtayo (cemiplimab) in Melanoma
August 3, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
